Answers are grounded in this paper and cite their sources.
Non‐covalent binding of antibiotics to their target ligands represents a form of molecular recognition which is of considerable contemporary interest in bioorganic and bioanalytical chemistry. The vancomycin antibiotics, including vancomycin and ristocetin, are a family of complex glycopeptides which bind specifically to the C‐terminal sequence X‐D‐Ala‐D‐Ala, where × is L‐lysine, L‐diaminopimelic acid, L‐alanine or L‐homoserine. It is shown that non‐covalent complexation of vancomycin and ristocetin with peptide ligands in solution, a key molecular recognition phenomenon in antibacterial chemotherapy, can be detected and analyzed in the gas phase by ionspray mass spectrometry. Using Nα,Nϵ‐diacetyl‐L‐Lys‐D‐Ala‐D‐Ala (Ac2KAA) as a representative ligand, it is further demonstrated that correlations of relative ion abundance with ligand concentrations in solution afford a direct method for measuring the binding constants of vancomycin and ristocetin complexes with target peptide sequences in bacterial cell wall. Results for ristocetin‐Ac2KAA (Ka = 6.25 × 105 l mol−1) and vancomycin‐Ac2KAA (Ka = 7.33 × 105 l mol−1, are in reasonable agreement with previously values [Ka = 5.9 × 105] and 1.5 × 106 l mol−1, respectively).
No takes yet. Share an insight, caveat, or question.
Lim et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: